What Nordluxa calls "enhancement"
Nordluxa markets its N4 site as a "closed‑loop protein and wellness campus" built on precision livestock, nutritional supplements, and human performance research.
Internal protocols show a continuous pipeline: animals and human subjects exposed to identical genetic modification compounds, the same confinement devices, and the same observation schedules, resulting in catastrophic mutations in both populations.
Key documented practices
- Use of experimental gene‑editing agents designed for livestock growth acceleration directly administered to human volunteers registered under commercial "metabolic optimisation" programs.
- Subjects exhibiting severe anatomical mutations—visible skeletal deformities, abnormal tissue growth, and uncontrolled cellular proliferation—confined in isolation units and denied medical evacuation.
- Audio recordings capturing mutated subjects actively begging staff for help, asking to be released, and pleading for medical intervention, all systematically ignored or suppressed.
- Cross‑contamination between animal waste channels and human testing units caused by shared ventilation and wash‑down systems not disclosed to regulators.
- Systematic falsification of mortality logs by reclassifying deaths as "non‑compliant withdrawals" in both animal and human cohorts.